4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Milestone Pharmaceuticals Inc. (MIST) operates in the Biotechnology industry and is headquartered in Montreal, Canada with about 38 employees. Its market capitalization is roughly $147 million. In the fiscal year ended 2025-12-31, MIST reported $2M in revenue and ($63M) in net income.
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada.
Interactive charts & full statements → Open the MIST valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $2M | $0M | $1M | $5M | — |
| Operating Income (EBIT) | ($62M) | ($42M) | ($61M) | ($60M) | — |
| Net Income | ($63M) | ($42M) | ($60M) | ($58M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $2M | $0M | $0M | $0M |
| Gross Profit | $0M | — | — | — | $0M |
| Operating Income (EBIT) | ($24M) | ($17M) | ($12M) | ($12M) | ($20M) |
| Net Income | ($26M) | ($17M) | ($12M) | ($13M) | ($21M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $114M | $76M | $75M | $74M | — |
| Total Liabilities | $72M | $62M | $58M | $8M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MIST viewer.
About TickerBase · Data methodology & sources